Library

Clear

Displaying 1,376 - 1,400 of 2,573

Other Targetable Agents (KRASg 12c, BRafv600, RET and NTRK)
Other Targetable Agents (KRASg 12c, BRafv600, RET and NTRK)
By: Edgardo S. Santos Castillero, MD, FACP
  View Video
EGFR, K-RAS and ERBB2 Mutations in NSCLC
EGFR, K-RAS and ERBB2 Mutations in NSCLC
By: Edgardo S. Santos Castillero, MD, FACP
  View PDF
EGFR, K-RAS and ERBB2 Mutations in NSCLC
EGFR, K-RAS and ERBB2 Mutations in NSCLC
By: Edgardo S. Santos Castillero, MD, FACP
  View Video
Novel Treatment for Unresectable Stage III NSCLC
Novel Treatment for Unresectable Stage III NSCLC
By: Edgardo S. Santos Castillero, MD, FACP
  View PDF
Novel Treatment for Unresectable Stage III NSCLC
Novel Treatment for Unresectable Stage III NSCLC
By: Edgardo S. Santos Castillero, MD, FACP
  View Video
Small Cell Lung Cancer
Small Cell Lung Cancer
By: Edgardo S. Santos Castillero, MD, FACP, FASCO
  View PDF
HER-3 as a New Target in NSCLC
HER-3 as a New Target in NSCLC
By: Edgardo S. Santos, MD
  View PDF
HER-3 as a New Target in NSCLC
HER-3 as a New Target in NSCLC
By: Edgardo S. Santos, MD
  View Video
Liquid Biopsy in the Management of Lung Cancer
Liquid Biopsy in the Management of Lung Cancer
By: Edgardo S. Santos, MD, FACP
  View PDF
EGFR & ALK: Where are We Now
EGFR & ALK: Where are We Now
By: Edgardo S. Santos, MD, FACP
  View PDF
RET, MET, & NTRK in Non-Small Cell Lung Cancer
RET, MET, & NTRK in Non-Small Cell Lung Cancer
By: Edgardo S. Santos, MD, FACP
  View PDF
RET, MET, and BRAF Mutant Lung Cancer Tumors
RET, MET, and BRAF Mutant Lung Cancer Tumors
By: Edgardo S. Santos, MD, FACP
  View PDF
EGFR/ALK and ROS-1 Lung Cancer Management
EGFR/ALK and ROS-1 Lung Cancer Management
By: Edgardo S. Santos, MD, FACP
  View PDF
Advances in Targeted Therapy in Lung Cancer
Advances in Targeted Therapy in Lung Cancer
By: Edgardo S. Santos, MD, FACP
  View PDF
Advances in Targeted Therapy in Lung Cancer
Advances in Targeted Therapy in Lung Cancer
By: Edgardo S. Santos, MD, FACP
  View Video
EGFR PKI Resistance and K-RAS Mutations
EGFR PKI Resistance and K-RAS Mutations
By: Edgardo S. Santos, MD, FACP
  View PDF